"The Petition to Reschedule Cannabis" was filed with the DEA in 2002 by Jon Gettman, PhD, Senior Fellow at George Mason University, with Patients Out of Time as a leading participant.

 The Petition's participants submitted approximately 50,000 pages of world-wide science based research on the medicinal uses of cannabis to the DEA for a review process that was completed in the fall of 2005. The DEA passed the Petition to their supervisory level, the Department of Health and Human Services, who by federal law had the responsibility of answering the Petition within 18 months (spring, 2007), yet still holds Dr. Gettman's demand in limbo. The passing of the Bush administration brings the hope that the newly nominated but continually delayed approval of the Surgeon General of the US will bring an end to this delay.

Patients Out of Time urges each citizen to ask their federal Senators and Representatives to expedite this pending, illegally delayed and compassionate citizen action.

Rescheduling Cannabis Under the U.S. Controlled Substances Act
Selected Bibliography, Time Line, and Reference Materials
by Jon Gettman, Ph.D

The above report was prepared for the 3rd National Clinical Conference on Cannabis Therapeutics, held in Charlottesville, Virginia in May, 2004. A video of this presentation follows:

Marijuana Rescheduling Petitions - a report by Jon Gettman, PhD -
Jon Gettman, Senior Fellow, George Mason University, examines reasons that Cannabis is still on Schedule I of the Controlled Substances Act, after 30 years of rescheduling petitions and scientific reviews before the DEA and HHS.

More on the Current Rescheduling Petition at www.drugscience.org

At the same 2004 conference, Professor Arnold Trebach recalls his involvement in a noted case of 1988, when the DEA's own law judge ruled that "Marijuana, in it's natural form, is one of the safest therapeutically active substances know to man".

1988 Marijuana Rescheduling Case before DEA, with Arnold Trebach, PhD, JD -
Arnold Trebach, Professor Emeritus, American University, recalls the petition brought before Drug Enforcement Administration Administrative Law Judge Francis L. Young. Although the DEA did not abide by his recommendation to reschedule Cannabis, Judge Young's findings on the safety and efficacy of medical marijuana are still relevant today.